GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (NAS:PACB) » Definitions » Shiller PE Ratio
中文

Pacific Biosciences of California (Pacific Biosciences of California) Shiller PE Ratio : (As of Apr. 24, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Pacific Biosciences of California Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pacific Biosciences of California Shiller PE Ratio Historical Data

The historical data trend for Pacific Biosciences of California's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Shiller PE Ratio Chart

Pacific Biosciences of California Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pacific Biosciences of California Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pacific Biosciences of California's Shiller PE Ratio

For the Medical Devices subindustry, Pacific Biosciences of California's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Shiller PE Ratio falls into.



Pacific Biosciences of California Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pacific Biosciences of California's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Pacific Biosciences of California's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.31/129.4194*129.4194
=-0.310

Current CPI (Dec. 2023) = 129.4194.

Pacific Biosciences of California Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.280 99.695 -0.363
201406 -0.270 100.560 -0.347
201409 -0.130 100.428 -0.168
201412 -0.260 99.070 -0.340
201503 -0.270 99.621 -0.351
201506 -0.160 100.684 -0.206
201509 0.020 100.392 0.026
201512 -0.020 99.792 -0.026
201603 -0.230 100.470 -0.296
201606 -0.210 101.688 -0.267
201609 -0.190 101.861 -0.241
201612 -0.200 101.863 -0.254
201703 -0.260 102.862 -0.327
201706 -0.260 103.349 -0.326
201709 -0.190 104.136 -0.236
201712 -0.180 104.011 -0.224
201803 -0.200 105.290 -0.246
201806 -0.170 106.317 -0.207
201809 -0.190 106.507 -0.231
201812 -0.210 105.998 -0.256
201903 -0.200 107.251 -0.241
201906 -0.160 108.070 -0.192
201909 -0.190 108.329 -0.227
201912 -0.001 108.420 -0.001
202003 0.010 108.902 0.012
202006 -0.150 108.767 -0.178
202009 -0.140 109.815 -0.165
202012 0.370 109.897 0.436
202103 -0.450 111.754 -0.521
202106 -0.210 114.631 -0.237
202109 0.080 115.734 0.089
202112 -0.310 117.630 -0.341
202203 -0.370 121.301 -0.395
202206 -0.320 125.017 -0.331
202209 -0.340 125.227 -0.351
202212 -0.370 125.222 -0.382
202303 -0.360 127.348 -0.366
202306 -0.280 128.729 -0.282
202309 -0.260 129.860 -0.259
202312 -0.310 129.419 -0.310

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pacific Biosciences of California  (NAS:PACB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pacific Biosciences of California Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California (Pacific Biosciences of California) Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.
Executives
Oene Mark Van officer: Chief Operating Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Christian O Henry director 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
David W Meline director 3M COMPANY, 3M OFFICE OF GENERAL COUNSEL, ST PAUL MN 55144-1000
Susan G. Kim officer: Chief Financial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Jeff Eidel officer: See Remarks 1305 O'BRIEN DR., MENLO PARK CA 94025
Michele Farmer officer: Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
William W. Ericson director 777 MARINERS ISLAND BOULEVARD, SUITE 550, SAN MATEO CA 94404
Peter Fromen officer: Chief Commercial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Hannah Valantine director 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Michael Hunkapiller director 400 HAMILTON AVENUE, 4TH FLOOR, PALO ALTO CA 94301
Eric Schaefer officer: VP Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Kathy Ordonez director 3 GIRALDA FARMS, C/O QUEST DIAGNOSTICS, MADISON NJ 07940
Randall S Livingston director
Lucy Shapiro director 10210 GENETIC CENTER COURT, SAN DIEGO CA 92121
David Botstein director 1380 WILLOW ROAD, PACIFIC BIOSCIENCES OF CALIFORNIA INC, MENLO PARK CA 94025